Unknown

Dataset Information

0

Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate.


ABSTRACT: In this study, approaches were developed to examine the phenotypes of nonviable clinical varicella-zoster virus (VZV) strains with amino acid substitutions in the thymidine kinase (TK) (open reading frame 36 [ORF36]) and/or DNA polymerase (Pol) (ORF28) suspected to cause resistance to antivirals. Initially, recombinant TK proteins containing amino acid substitutions described as known or suspected causes of antiviral resistance were analyzed by measuring the TK activity by applying a modified commercial enzyme immunoassay. To examine the effects of these TK and Pol substitutions on the replication of recombinant virus strains, the method of en passant mutagenesis was used. Targeted mutations within ORF36 and/or ORF28 and an autonomously expressed gene of the monomeric red fluorescent protein for plaque identification were introduced into the European wild-type VZV strain HJO. Plaque reduction assays revealed that the amino acid substitutions with unknown functions in TK, Q303stop, N334stop, A163stop, and the deletion of amino acids 7 to 74 aa (?aa 7 to 74), were associated with resistance against acyclovir (ACV), penciclovir, or brivudine, whereas the L73I substitution and the Pol substitutions T237K and A955T revealed sensitive viral phenotypes. The results were confirmed by quantitative PCR by measuring the viral load under increasing ACV concentrations. In conclusion, analyzing the enzymatic activities of recombinant TK proteins represent a useful tool for evaluating the significance of amino acid substitutions in the antiviral resistance of clinical VZV strains. However, direct testing of replication-competent viruses by the introduction of nonsynonymous mutations in a VZV bacterial artificial chromosome using en passant mutagenesis led to reliable phenotypic characterization results.

SUBMITTER: Brunnemann AK 

PROVIDER: S-EPMC4394776 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate.

Brunnemann Anne-Kathrin AK   Bohn-Wippert Kathrin K   Zell Roland R   Henke Andreas A   Walther Martin M   Braum Oliver O   Maschkowitz Gregor G   Fickenscher Helmut H   Sauerbrei Andreas A   Krumbholz Andi A  

Antimicrobial agents and chemotherapy 20150223 5


In this study, approaches were developed to examine the phenotypes of nonviable clinical varicella-zoster virus (VZV) strains with amino acid substitutions in the thymidine kinase (TK) (open reading frame 36 [ORF36]) and/or DNA polymerase (Pol) (ORF28) suspected to cause resistance to antivirals. Initially, recombinant TK proteins containing amino acid substitutions described as known or suspected causes of antiviral resistance were analyzed by measuring the TK activity by applying a modified co  ...[more]

Similar Datasets

| S-EPMC6496055 | biostudies-literature
| S-EPMC89493 | biostudies-literature
| S-EPMC3118253 | biostudies-literature
| S-EPMC10747211 | biostudies-literature
| S-EPMC2772622 | biostudies-literature
| S-EPMC2885040 | biostudies-literature
| S-EPMC2519472 | biostudies-literature
| S-EPMC4181020 | biostudies-literature
| S-EPMC9227806 | biostudies-literature
| S-EPMC115131 | biostudies-literature